IPO Guru

IPO Listed — 08 Oct 2025

Listing Price: ₹114 (+14% vs ₹100)

View GMP History →
Advance Agrolife

Advance Agrolife IPO Review

Advance Agrolife IPO has been reviewed by 5 analysts, and the overall consensus is Apply — carrying a score of 80. Out of the 5 analysts who have covered this IPO, 3 recommend subscribing while 2 advise caution or avoidance — reflecting a broadly positive view from the analyst community.

The issue is priced in the band of ₹95-100 per share , with a minimum application size of 150 shares (minimum investment of approximately ₹15,000 at the upper band) . Subscription ran from 30 Sep 2025 to 03 Oct 2025. Scroll down for the full analyst breakdown and analyst-wise verdicts.

General Review

Advance Agrolife manufactures agrochemicals. Revenue grew steadily from ₹397.97 crore in FY23 to ₹502.88 crore in FY25, with operating margin improving each year from 6.3 to 9.5 percent and EBITDA reaching ₹48.25 crore. Of the five analysts covering it, three said subscribe and two stayed neutral.

Listing Gains

Coverage was limited and the tone measured, with three subscribe ratings against two neutral views on a small ₹193 crore issue priced at ₹95 to ₹100. The absence of any strong valuation argument in the notes, in either direction, pointed to a modest listing expectation.

Short Term Strategy

The margin trend is the clearest positive, rising from 6.3 percent in FY23 to 8.5 percent in FY24 and 9.5 percent in FY25 on steadily growing revenue. Agrochemical demand depends on the monsoon and crop cycle, so near-term earnings carry the usual seasonal variability.

Long Term Strategy

The long-term case rests on consistent revenue growth with expanding margins in a sector supported by structural agricultural demand. With only three positive notes and no detailed valuation case published, the coverage gives a modest rather than emphatic endorsement for a long holding period.

Disclaimer: This review is an AI summary derived from the reviews of all analysts.

Analyst Sentiment

Analytical Score

How it's calculated?
Apply
80 / 100

Recommend Subscribe

Based on 5 analyst reviews

3 / 5

Higher consensus indicates broader analyst agreement.

Analyst Review

Latest IPO Reviews

Frequently Asked Questions

Should I apply for Advance Agrolife IPO?

Based on analyst coverage tracked on this page, the overall verdict for Advance Agrolife IPO is Apply. Out of 5 analysts who have reviewed this IPO, 3 recommend subscribing. Always cross-check with the full analyst reviews below and consult a SEBI-registered advisor before making any investment decision.

What does the score of 80 mean for Advance Agrolife IPO?

The score of 80 is an aggregate of all analyst ratings tracked for Advance Agrolife IPO. A score in this range indicates strong analyst confidence — most analysts are recommending a subscribe. Scroll down to read individual analyst verdicts for more context.

What was the actual listing price of Advance Agrolife IPO?

Advance Agrolife IPO listed on October 8, 2025 at ₹114 , against the issue price of ₹100 — a gain of +14% (₹14 per share). View the full GMP history page for day-wise pre-listing trends.

What is the price band and lot size of Advance Agrolife IPO?

Advance Agrolife IPO was priced at ₹95-100 per share. The minimum lot size is 150 shares, making the minimum investment approximately ₹15,000 at the upper end of the price band. Subscription ran from 30 Sep 2025 to 03 Oct 2025.

Explore Advance Agrolife IPO Further

Track every stage of this IPO:

Advertisement
Disclaimer: Grey Market Premium (GMP) is for information purposes and is not a guarantee of listing price. Always consult your financial advisor before investing.